Unresectable Urothelial Carcinoma
13 clinical trials · Condition
◉ Watch Unresectable Urothelial Carcinoma
| Record | Firm | Date |
|---|---|---|
| Tremelimumab + Durvalumab(MEDI4736)+ Belinostat in Urothelial Carcinoma (NCT05154994) | University of Utah | 2022-01-14 |
| Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer (NCT04491942) | National Cancer Institute (NCI) | 2021-08-25 |
| Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer (NCT04878029) | Emory University | 2021-07-23 |
| Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205) (NCT04003610) | Incyte Corporation | 2020-05-14 |
| Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer (NCT00942331) | National Cancer Institute (NCI) | 2009-07-15 |
Track Unresectable Urothelial Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.